A couple has been diagnosed with infertility after trying to conceive for a year.
Which test would likely be performed first?
Semen analysis
Transvaginal ultrasound
Hysterosalpingography
Hysteroscopy
The Correct Answer is A
Choice A rationale:
Semen analysis is the initial test often performed in the evaluation of infertility. It's a non-invasive, cost-effective, and informative assessment of male fertility. Here's a detailed explanation of its significance:
Assessment of Sperm Quality:
Measures sperm count, motility (movement), and morphology (shape).
Abnormalities in any of these parameters can significantly impact the chances of conception.
Identification of Male Factor Infertility:
Contributes to approximately 40% of infertility cases.
Early identification of male factor infertility guides treatment options and avoids unnecessary testing for the female partner.
Non-Invasive and Cost-Effective:
Simple procedure involving the collection of a semen sample.
Relatively inexpensive compared to other fertility tests.
Informative Results:
Provides valuable insights into sperm health and potential causes of infertility.
Guides further diagnostic evaluation and treatment strategies.
Rationale for other choices:
Choice B: Transvaginal ultrasound
Primarily evaluates female reproductive organs.
Assesses uterine structure, ovarian function, and potential abnormalities like fibroids or cysts.
Not typically the first test in infertility evaluation unless there's a specific female-factor concern.
Choice C: Hysterosalpingography (HSG)
Assesses the patency of the fallopian tubes.
Involves X-ray imaging after injecting contrast dye into the uterus.
Often performed after semen analysis if male factor infertility is not identified.
Choice D: Hysteroscopy
A more invasive procedure involving direct visualization of the inside of the uterus.
Used to diagnose and treat uterine abnormalities such as polyps or fibroids.
Not typically a first-line test in infertility evaluation.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
Choice A rationale:
Incorrect. The quad screen test does not examine fetal DNA to determine gender. That is the role of other tests, such as amniocentesis or chorionic villus sampling (CVS).
Gender determination is not a primary objective of the quad screen test.
Focusing on gender unnecessarily narrows the scope of the test's potential findings.
Choice B rationale:
Incorrect. The quad screen test does not use fetal tissue. It is a non-invasive blood test that measures levels of four substances in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A.
Fetal tissue sampling is more invasive and carries risks, while the quad screen is a safer alternative.
Clarifying the non-invasive nature of the test is crucial for informed consent and patient understanding.
Choice C rationale:
Incorrect. While AFP levels can be affected by maternal liver function, that is not the primary focus of the quad screen test.
Liver function tests are specifically designed to assess liver health, and they are not part of the quad screen panel.
Distinguishing between liver function assessment and AFP's role in screening for fetal anomalies is essential for accurate interpretation.
Choice D rationale:
Correct. The quad screen test measures levels of AFP, hCG, uE3, and inhibin A in the mother's blood. These substances can provide information about the risk of certain fetal chromosomal abnormalities and neural tube defects.
Elevated AFP levels can indicate an increased risk for neural tube defects such as spina bifida or anencephaly.
Low AFP levels can be associated with Down syndrome or other chromosomal abnormalities.
Understanding the specific disorders that can be indicated by AFP levels is crucial for patient counseling and further testing decisions.
Correct Answer is A
Explanation
Choice A rationale:
Amniocentesis is the most reliable and direct method to assess fetal lung maturity. It involves the extraction of a small sample of amniotic fluid from the amniotic sac, which surrounds the fetus in the uterus. This fluid contains various substances, including surfactant, which is a crucial substance produced by the fetal lungs that enables them to expand and function properly after birth.
By analyzing the levels of surfactant and other components in the amniotic fluid, clinicians can accurately determine the maturity of the fetal lungs. This information is essential in guiding decisions about potential delivery options, especially in cases of preterm labor or other complications that may necessitate early delivery.
Amniocentesis is generally considered a safe procedure, but it does carry some small risks, such as infection, bleeding, or amniotic fluid leakage. However, these risks are typically outweighed by the benefits of obtaining accurate information about fetal lung maturity when necessary.
Choice B rationale:
Fetal fibronectin (fFN) is a protein that is found in the amniotic fluid and cervicovaginal secretions. Elevated levels of fFN in cervicovaginal secretions between 22 and 34 weeks of gestation can indicate an increased risk of preterm labor.
However, fFN testing is not a direct measure of fetal lung maturity. It is used primarily as a screening tool to assess the risk of preterm birth, not to determine the readiness of the fetal lungs for delivery.
Choice C rationale:
Chorionic villus sampling (CVS) is a prenatal diagnostic test that involves taking a small sample of chorionic villi, which are tiny finger-like projections of placental tissue. This test is typically performed earlier in pregnancy (between 10 and 13 weeks gestation) to diagnose genetic abnormalities in the fetus.
CVS is not used to assess fetal lung maturity. It does not provide any information about the development of the fetal lungs or their readiness for birth.
Choice D rationale:
Alpha-fetoprotein (AFP) is a protein produced by the fetal liver. Elevated levels of AFP in the maternal blood can indicate an increased risk of certain birth defects, such as neural tube defects.
AFP testing is not used to assess fetal lung maturity. It does not provide any information about the development of the fetal lungs or their readiness for birth.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.